Dupilumab in atopic dermatitis: rationale, latest evidence and place in therapy

Atopic dermatitis (AD) is one of the most common chronic inflammatory skin diseases. The prevalence of AD is increasing and is currently estimated at 10–20% in adults worldwide. In the majority of patients, AD can be adequately controlled with topical treatment or ultraviolet light therapy, but ther...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Ther Adv Chronic Dis
Hoofdauteurs: Ariëns, Lieneke F.M., Bakker, Daphne S., van der Schaft, Jorien, Garritsen, Floor M., Thijs, Judith L., de Bruin-Weller, Marjolein S.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: SAGE Publications 2018
Onderwerpen:
Review
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6116085/
https://ncbi.nlm.nih.gov/pubmed/30181845
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040622318773686
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items